Biomarker studies: a call for a comprehensive biomarker study registry. - Wikidata - wikimedia - TriplyDB

Biomarker studies: a call for a comprehensive biomarker study registry.

Biomarker studies: a call for a comprehensive biomarker study registry.

http://www.wikidata.org/entity/Q37848667

about

Knowledge Integration in Cancer: Current Landscape and Future Prospects Predicting Clinical Outcomes Using Molecular Biomarkers Biomarker validation and testing Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.Computational modelling of anti-angiogenic therapies based on multiparametric molecular imaging data Humoral response to a viral glycan correlates with survival on PROSTVAC-VF Search filters for finding prognostic and diagnostic prediction studies in Medline to enhance systematic reviews.Statistical challenges in the development and evaluation of marker-based clinical tests.Resolving breast cancer heterogeneity by searching reliable protein cancer biomarkers in the breast fluid secretome.Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.Safety and diagnostic accuracy of tumor biopsies in children with cancer.Leveling the playing field: bringing development of biomarkers and molecular diagnostics up to the standards for drug development Publication of tumor marker research results: the necessity for complete and transparent reporting.Reporting practices of pharmacodynamic studies involving invasive research procedures in cancer trials.Assessment of the extent of unpublished studies in prognostic factor research: a systematic review of p53 immunohistochemistry in bladder cancer as an example Beyond PSA: the next generation of prostate cancer biomarkers.In Pursuit of Greater Reproducibility and Credibility of Early Clinical Biomarker Research.Somatic variation and cancer: therapies lost in the mix.miRNAs in breast cancer: ready for real time?Translating metastasis-related biomarkers to the clinic--progress and pitfalls.Breaking a vicious cycle.Developing translational research infrastructure and capabilities associated with cancer clinical trials.Microfluidic platforms for biomarker analysis.The national biomarker development alliance: confronting the poor productivity of biomarker research and development.Reproducibility in biomarker research and clinical development: a global challenge.Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles.Prevention of selective outcome reporting: let us start from the beginning.New drug developments in psychosis: Challenges, opportunities and strategies.New therapeutic perspectives in CCDC6 deficient lung cancer cells.A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer.Pharmacogenomic substudies of randomized controlled trials: consideration of safety outcomes.Improving validation practices in "omics" research.The Challenges of Validating in Precision Medicine: The Case of Excision Repair Cross-Complement Group 1 Diagnostic Testing.Back to the future in bladder cancer research.Reproducibility of research and preclinical validation: problems and solutions.Seeking the driver in tumours with apparent normal molecular profile on comparative genomic hybridization and targeted gene panel sequencing: what is the added value of whole exome sequencing?Comment on 'BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses'

P2860

Q24289007-19C8758F-450C-4A4F-A467-569C63C69BA6 Q26747424-7250696B-A831-4ED2-9CB9-7B80B2DD2A26 Q26863672-C002949D-4A1C-4524-9BCB-6052B0DE33C1 Q30514241-923BDCE6-2BD4-4BD8-B620-28487A6BECF0 Q30564565-694C52D8-6802-48C1-A143-8AB88EA024B6 Q33674367-D7C54596-4309-4A17-AFB0-52224A8E4E57 Q34186027-41A105CF-B36B-4737-A171-98702CE89DA7 Q34285269-41BC8641-F628-4B68-8B28-547C113E2196 Q34815370-A8A27212-3496-4C7D-99EC-F5D324046B0A Q35127253-72230A2C-FDAA-4217-84BB-4D87870D1832 Q35202350-2F8D8E56-A890-464A-8FD3-2CEC2ED6F390 Q35838562-D664D4F9-C7F6-4555-A9A4-6FA3EA3B4581 Q36417739-954A937F-D821-476B-BDD0-CA1E3B108D7F Q37111197-53591E16-15B8-41C3-BCBE-EDD73149413B Q37236560-C6D9630F-718B-457E-ACF7-8E819ADD1FFC Q37238101-30A5BFDE-C053-42BE-A47F-5E1395002D0A Q37708025-E33BCB37-12FD-4B9A-8AAD-1B334F8D3586 Q37885276-DC74C5CD-37E8-489C-84BD-496A4F1DECFD Q38003705-76788589-6693-4FF2-92A9-64A30AD80847 Q38079125-5208369C-C0C8-4A7E-938D-1801E171FB76 Q38125603-5E52DC02-65C7-4A9D-A3BE-48389C0FDA8F Q38145438-E9248383-7964-4BC0-9F69-FB2B37294114 Q38198962-486B7F56-9425-4621-BFED-BBFC3D02A1D2 Q38270923-711243A4-58BD-46A5-99A6-623EE130DDAE Q38372271-09B33BA1-8809-482C-8D99-09BE21EB1328 Q38671095-0B1C85F7-A941-4A71-8EEF-414DAB14414B Q38835242-43BE7BAA-A7C5-46AB-846D-917CDA56B1F7 Q38926246-DD3192CF-AFFC-401D-8D78-66D131A46AD4 Q38949133-AF312C97-03C0-4F44-8185-FA690C9BB8E7 Q39112227-56A0B408-B88D-43DA-B3FF-A2076F07949F Q41764396-3309829D-0D62-499D-8BA6-7488462EFCBE Q42112095-7CAEB108-DDB1-4E4D-99CE-0C2DFA759F25 Q47110861-7A2C45D2-88FB-4AB1-A414-6DD3269C966E Q51700873-6BE17C46-F19A-4842-B605-A3F6AE5067C1 Q53127167-0D605A7F-ACFA-4820-9B0F-2DDE01B4CD43 Q53267051-305AAB41-539C-411C-8E97-CC1220134C19 Q57113748-7E3A9D37-8777-452F-8F99-C2D094C7CFF7

P2860

Biomarker studies: a call for a comprehensive biomarker study registry.

http://www.wikidata.org/entity/Q37848667

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Biomarker studies: a call for a comprehensive biomarker study registry.

@en

Biomarker studies: a call for a comprehensive biomarker study registry.

@nl

type

label

Biomarker studies: a call for a comprehensive biomarker study registry.

@en

Biomarker studies: a call for a comprehensive biomarker study registry.

@nl

prefLabel

Biomarker studies: a call for a comprehensive biomarker study registry.

@en

Biomarker studies: a call for a comprehensive biomarker study registry.

@nl

P1433

Q37848667-D0F1CA13-45A5-470C-9962-B6D57F9431A1

P1476

Q37848667-DB733DC7-D01F-4FB9-9A80-90B4585C8838

P2093

Q37848667-233EA0F1-6EC4-4EB3-952D-5061B279E46C

Q37848667-99CE9E51-3749-4A42-A7DB-592BF03D571C

Q37848667-A736F678-238F-4224-B2AB-84FF3B54EF1D

Q37848667-B116A919-9BDD-46A0-84B6-C6CB4C95FE03

Q37848667-F61ABF21-BAB1-49B8-9F77-972EC2B8D090

P2888

Q37848667-EB584D16-F15C-4008-B6DB-5228FC5DDAD2

P304

Q37848667-6D9A60E8-C4DA-414D-955E-D67FAAE00534

P31

Q37848667-23BF7166-AE42-46E7-B805-BBADCFC7E142

P356

Q37848667-49A219DC-7830-48BD-98A9-61D1834CBF11

P407

Q37848667-8DF8E824-5120-4A51-9E9A-779549992EF3

P433

Q37848667-AA030258-B882-4603-90DD-75CCB8A6CF58

P478

Q37848667-E376F5A2-8DA9-49D0-B209-21469B650C90

P50

Q37848667-7466F4E2-0C8D-486C-90DF-C67259B9FC52

Q37848667-A3C627DA-72F4-4EDC-BD81-3796886CF11D

Q37848667-F4F6127D-2776-47B4-B1D6-05203955EE72

P577

Q37848667-48B63A14-7921-4E0B-A87F-8E49CDF552BC

P5875

Q37848667-3AC98BFE-690A-49BE-BDDC-3A7AC99F3197

P6179

Q37848667-EFF78A43-868D-4C11-8288-B06D924FC046

P698

Q37848667-9E001FB1-C1C4-43F6-A485-A07B6A13C49E

P921

Q37848667-4D701E94-1BCA-40AA-96D7-2F746ACD6482

P356

NRCLINONC.2011.4

P1433

Nature Reviews Clinical Oncology

P1476

Biomarker studies: a call for a comprehensive biomarker study registry.

@en

P2093

Daniel F Hayes

http://www.w3.org/2001/XMLSchema#string

David F Ransohoff

http://www.w3.org/2001/XMLSchema#string

Fabrice Andre

http://www.w3.org/2001/XMLSchema#string

Lajos Pusztai

http://www.w3.org/2001/XMLSchema#string

Lisa M McShane

http://www.w3.org/2001/XMLSchema#string

P2888

nrclinonc.2011.4

P304

171-176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRCLINONC.2011.4

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Jorge Reis-Filho

Stefan Michiels

Douglas G. Altman

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50250608

http://www.w3.org/2001/XMLSchema#string

P6179

1004590825

http://www.w3.org/2001/XMLSchema#string

P698

21364690

http://www.w3.org/2001/XMLSchema#string

P921